nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—ABCC1—Epirubicin—ovarian cancer	0.136	0.207	CbGbCtD
Abiraterone—ABCC1—Paclitaxel—ovarian cancer	0.134	0.204	CbGbCtD
Abiraterone—ABCC1—Docetaxel—ovarian cancer	0.097	0.147	CbGbCtD
Abiraterone—ABCC1—Doxorubicin—ovarian cancer	0.0723	0.11	CbGbCtD
Abiraterone—CYP2C8—Paclitaxel—ovarian cancer	0.0478	0.0727	CbGbCtD
Abiraterone—CYP2D6—Vinorelbine—ovarian cancer	0.0434	0.066	CbGbCtD
Abiraterone—CYP3A4—Topotecan—ovarian cancer	0.0392	0.0596	CbGbCtD
Abiraterone—CYP17A1—ovarian follicle—ovarian cancer	0.0304	0.321	CbGeAlD
Abiraterone—CYP3A4—Vinorelbine—ovarian cancer	0.0276	0.042	CbGbCtD
Abiraterone—CYP3A4—Paclitaxel—ovarian cancer	0.0194	0.0295	CbGbCtD
Abiraterone—CYP2D6—Doxorubicin—ovarian cancer	0.0164	0.025	CbGbCtD
Abiraterone—CYP3A4—Docetaxel—ovarian cancer	0.014	0.0213	CbGbCtD
Abiraterone—CYP3A4—Doxorubicin—ovarian cancer	0.0105	0.0159	CbGbCtD
Abiraterone—SULT2A1—gonad—ovarian cancer	0.0064	0.0676	CbGeAlD
Abiraterone—SULT2A1—female reproductive system—ovarian cancer	0.00572	0.0604	CbGeAlD
Abiraterone—SULT2A1—female gonad—ovarian cancer	0.0052	0.055	CbGeAlD
Abiraterone—SULT2A1—testis—ovarian cancer	0.00461	0.0487	CbGeAlD
Abiraterone—SULT2A1—lymph node—ovarian cancer	0.00334	0.0353	CbGeAlD
Abiraterone—CYP17A1—gonad—ovarian cancer	0.00279	0.0294	CbGeAlD
Abiraterone—CYP17A1—female reproductive system—ovarian cancer	0.00249	0.0263	CbGeAlD
Abiraterone—CYP17A1—female gonad—ovarian cancer	0.00226	0.0239	CbGeAlD
Abiraterone—ABCC1—myometrium—ovarian cancer	0.00217	0.0229	CbGeAlD
Abiraterone—ORM1—endometrium—ovarian cancer	0.00211	0.0223	CbGeAlD
Abiraterone—CYP17A1—testis—ovarian cancer	0.00201	0.0212	CbGeAlD
Abiraterone—ORM1—female reproductive system—ovarian cancer	0.00175	0.0185	CbGeAlD
Abiraterone—ABCC1—uterine cervix—ovarian cancer	0.00169	0.0178	CbGeAlD
Abiraterone—ORM1—bone marrow—ovarian cancer	0.00165	0.0174	CbGeAlD
Abiraterone—ABCC1—decidua—ovarian cancer	0.00161	0.017	CbGeAlD
Abiraterone—ABCC1—endometrium—ovarian cancer	0.00153	0.0161	CbGeAlD
Abiraterone—CYP17A1—lymph node—ovarian cancer	0.00146	0.0154	CbGeAlD
Abiraterone—ABCC1—uterus—ovarian cancer	0.00141	0.0149	CbGeAlD
Abiraterone—CYP2C8—endometrium—ovarian cancer	0.0013	0.0137	CbGeAlD
Abiraterone—ALB—testis—ovarian cancer	0.00124	0.0131	CbGeAlD
Abiraterone—Testosterone—CYP1B1—ovarian cancer	0.00116	0.777	CrCbGaD
Abiraterone—ABCC1—female gonad—ovarian cancer	0.00115	0.0122	CbGeAlD
Abiraterone—ABCC1—vagina—ovarian cancer	0.00114	0.0121	CbGeAlD
Abiraterone—CYP2C8—female reproductive system—ovarian cancer	0.00108	0.0114	CbGeAlD
Abiraterone—ORM1—lymph node—ovarian cancer	0.00102	0.0108	CbGeAlD
Abiraterone—ABCC1—testis—ovarian cancer	0.00102	0.0108	CbGeAlD
Abiraterone—CYP2C8—vagina—ovarian cancer	0.000974	0.0103	CbGeAlD
Abiraterone—ALB—lymph node—ovarian cancer	0.000896	0.00947	CbGeAlD
Abiraterone—CYP2C8—testis—ovarian cancer	0.000869	0.00918	CbGeAlD
Abiraterone—Arrhythmia—Vinorelbine—ovarian cancer	0.000747	0.00368	CcSEcCtD
Abiraterone—Cough—Topotecan—ovarian cancer	0.000743	0.00365	CcSEcCtD
Abiraterone—Hypokalaemia—Paclitaxel—ovarian cancer	0.00074	0.00364	CcSEcCtD
Abiraterone—ABCC1—lymph node—ovarian cancer	0.00074	0.00782	CbGeAlD
Abiraterone—Hot flush—Docetaxel—ovarian cancer	0.000737	0.00362	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Paclitaxel—ovarian cancer	0.000732	0.0036	CcSEcCtD
Abiraterone—Menopausal symptoms—Docetaxel—ovarian cancer	0.000731	0.00359	CcSEcCtD
Abiraterone—CYP3A4—female reproductive system—ovarian cancer	0.000729	0.00771	CbGeAlD
Abiraterone—Cough—Melphalan—ovarian cancer	0.000727	0.00358	CcSEcCtD
Abiraterone—Nasopharyngitis—Paclitaxel—ovarian cancer	0.000727	0.00358	CcSEcCtD
Abiraterone—Chest pain—Topotecan—ovarian cancer	0.000725	0.00356	CcSEcCtD
Abiraterone—Myalgia—Topotecan—ovarian cancer	0.000725	0.00356	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00072	0.00354	CcSEcCtD
Abiraterone—CYP2D6—female reproductive system—ovarian cancer	0.000718	0.00758	CbGeAlD
Abiraterone—Alanine aminotransferase increased—Paclitaxel—ovarian cancer	0.000717	0.00353	CcSEcCtD
Abiraterone—Discomfort—Topotecan—ovarian cancer	0.000716	0.00352	CcSEcCtD
Abiraterone—Chest pain—Melphalan—ovarian cancer	0.00071	0.00349	CcSEcCtD
Abiraterone—Myalgia—Melphalan—ovarian cancer	0.00071	0.00349	CcSEcCtD
Abiraterone—Cardiac failure—Docetaxel—ovarian cancer	0.000706	0.00347	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000705	0.00347	CcSEcCtD
Abiraterone—Nocturia—Epirubicin—ovarian cancer	0.00069	0.0034	CcSEcCtD
Abiraterone—Infection—Topotecan—ovarian cancer	0.00069	0.00339	CcSEcCtD
Abiraterone—Dyspepsia—Chlorambucil—ovarian cancer	0.000687	0.00338	CcSEcCtD
Abiraterone—Oedema—Melphalan—ovarian cancer	0.00068	0.00335	CcSEcCtD
Abiraterone—Infection—Melphalan—ovarian cancer	0.000676	0.00332	CcSEcCtD
Abiraterone—Skin disorder—Topotecan—ovarian cancer	0.000675	0.00332	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000674	0.00331	CcSEcCtD
Abiraterone—Anaemia—Vinorelbine—ovarian cancer	0.000673	0.00331	CcSEcCtD
Abiraterone—Fatigue—Chlorambucil—ovarian cancer	0.000673	0.00331	CcSEcCtD
Abiraterone—Skin disorder—Melphalan—ovarian cancer	0.000661	0.00325	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Paclitaxel—ovarian cancer	0.000653	0.00321	CcSEcCtD
Abiraterone—CYP2D6—female gonad—ovarian cancer	0.000653	0.0069	CbGeAlD
Abiraterone—Pollakiuria—Paclitaxel—ovarian cancer	0.000649	0.00319	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Epirubicin—ovarian cancer	0.000641	0.00315	CcSEcCtD
Abiraterone—Nocturia—Doxorubicin—ovarian cancer	0.000639	0.00314	CcSEcCtD
Abiraterone—Cough—Vinorelbine—ovarian cancer	0.000635	0.00313	CcSEcCtD
Abiraterone—Hyperglycaemia—Paclitaxel—ovarian cancer	0.000634	0.00312	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000633	0.00311	CcSEcCtD
Abiraterone—Pneumonia—Paclitaxel—ovarian cancer	0.00063	0.0031	CcSEcCtD
Abiraterone—Hypertension—Vinorelbine—ovarian cancer	0.000629	0.00309	CcSEcCtD
Abiraterone—Infestation NOS—Paclitaxel—ovarian cancer	0.000627	0.00308	CcSEcCtD
Abiraterone—Infestation—Paclitaxel—ovarian cancer	0.000627	0.00308	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.000621	0.00305	CcSEcCtD
Abiraterone—Chest pain—Vinorelbine—ovarian cancer	0.00062	0.00305	CcSEcCtD
Abiraterone—Myalgia—Vinorelbine—ovarian cancer	0.00062	0.00305	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00062	0.00305	CcSEcCtD
Abiraterone—Dyspnoea—Topotecan—ovarian cancer	0.000619	0.00305	CcSEcCtD
Abiraterone—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.000618	0.00304	CcSEcCtD
Abiraterone—Body temperature increased—Chlorambucil—ovarian cancer	0.000617	0.00303	CcSEcCtD
Abiraterone—Nasopharyngitis—Docetaxel—ovarian cancer	0.000616	0.00303	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000616	0.00303	CcSEcCtD
Abiraterone—Myocardial infarction—Paclitaxel—ovarian cancer	0.000614	0.00302	CcSEcCtD
Abiraterone—Discomfort—Vinorelbine—ovarian cancer	0.000612	0.00301	CcSEcCtD
Abiraterone—Dyspepsia—Topotecan—ovarian cancer	0.000611	0.00301	CcSEcCtD
Abiraterone—Urinary tract infection—Paclitaxel—ovarian cancer	0.000609	0.003	CcSEcCtD
Abiraterone—Fluid retention—Epirubicin—ovarian cancer	0.000608	0.00299	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.000608	0.00299	CcSEcCtD
Abiraterone—Dyspnoea—Melphalan—ovarian cancer	0.000606	0.00298	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Topotecan—ovarian cancer	0.0006	0.00295	CcSEcCtD
Abiraterone—Fatigue—Topotecan—ovarian cancer	0.000599	0.00295	CcSEcCtD
Abiraterone—Dyspepsia—Melphalan—ovarian cancer	0.000599	0.00295	CcSEcCtD
Abiraterone—Haematuria—Paclitaxel—ovarian cancer	0.000598	0.00294	CcSEcCtD
Abiraterone—Constipation—Topotecan—ovarian cancer	0.000594	0.00292	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Doxorubicin—ovarian cancer	0.000593	0.00292	CcSEcCtD
Abiraterone—Infection—Vinorelbine—ovarian cancer	0.00059	0.0029	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000587	0.00289	CcSEcCtD
Abiraterone—Fatigue—Melphalan—ovarian cancer	0.000586	0.00288	CcSEcCtD
Abiraterone—CYP2D6—testis—ovarian cancer	0.000579	0.00612	CbGeAlD
Abiraterone—Skin disorder—Vinorelbine—ovarian cancer	0.000577	0.00284	CcSEcCtD
Abiraterone—Fluid retention—Doxorubicin—ovarian cancer	0.000563	0.00277	CcSEcCtD
Abiraterone—Asthenia—Chlorambucil—ovarian cancer	0.00056	0.00275	CcSEcCtD
Abiraterone—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000556	0.00273	CcSEcCtD
Abiraterone—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000553	0.00272	CcSEcCtD
Abiraterone—Urethral disorder—Paclitaxel—ovarian cancer	0.000551	0.00271	CcSEcCtD
Abiraterone—Body temperature increased—Topotecan—ovarian cancer	0.000549	0.0027	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000541	0.00266	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.000535	0.00263	CcSEcCtD
Abiraterone—Pneumonia—Docetaxel—ovarian cancer	0.000534	0.00263	CcSEcCtD
Abiraterone—Diarrhoea—Chlorambucil—ovarian cancer	0.000534	0.00263	CcSEcCtD
Abiraterone—Infestation—Docetaxel—ovarian cancer	0.000531	0.00261	CcSEcCtD
Abiraterone—Infestation NOS—Docetaxel—ovarian cancer	0.000531	0.00261	CcSEcCtD
Abiraterone—Dyspnoea—Vinorelbine—ovarian cancer	0.00053	0.00261	CcSEcCtD
Abiraterone—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000524	0.00258	CcSEcCtD
Abiraterone—Cardiac disorder—Paclitaxel—ovarian cancer	0.000522	0.00257	CcSEcCtD
Abiraterone—Myocardial infarction—Docetaxel—ovarian cancer	0.000521	0.00256	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000513	0.00252	CcSEcCtD
Abiraterone—Fatigue—Vinorelbine—ovarian cancer	0.000512	0.00252	CcSEcCtD
Abiraterone—Angiopathy—Paclitaxel—ovarian cancer	0.00051	0.00251	CcSEcCtD
Abiraterone—Constipation—Vinorelbine—ovarian cancer	0.000508	0.0025	CcSEcCtD
Abiraterone—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000507	0.00249	CcSEcCtD
Abiraterone—Arrhythmia—Paclitaxel—ovarian cancer	0.000503	0.00247	CcSEcCtD
Abiraterone—Asthenia—Topotecan—ovarian cancer	0.000498	0.00245	CcSEcCtD
Abiraterone—Hot flush—Epirubicin—ovarian cancer	0.000497	0.00244	CcSEcCtD
Abiraterone—Vomiting—Chlorambucil—ovarian cancer	0.000496	0.00244	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.000495	0.00243	CcSEcCtD
Abiraterone—Mental disorder—Paclitaxel—ovarian cancer	0.000493	0.00242	CcSEcCtD
Abiraterone—Menopausal symptoms—Epirubicin—ovarian cancer	0.000493	0.00242	CcSEcCtD
Abiraterone—Asthenia—Melphalan—ovarian cancer	0.000488	0.0024	CcSEcCtD
Abiraterone—Cardiac failure—Epirubicin—ovarian cancer	0.000476	0.00234	CcSEcCtD
Abiraterone—Diarrhoea—Topotecan—ovarian cancer	0.000475	0.00234	CcSEcCtD
Abiraterone—Urinary tract disorder—Docetaxel—ovarian cancer	0.000471	0.00232	CcSEcCtD
Abiraterone—Body temperature increased—Vinorelbine—ovarian cancer	0.00047	0.00231	CcSEcCtD
Abiraterone—Connective tissue disorder—Docetaxel—ovarian cancer	0.000469	0.0023	CcSEcCtD
Abiraterone—Urethral disorder—Docetaxel—ovarian cancer	0.000467	0.0023	CcSEcCtD
Abiraterone—Diarrhoea—Melphalan—ovarian cancer	0.000465	0.00229	CcSEcCtD
Abiraterone—Hot flush—Doxorubicin—ovarian cancer	0.00046	0.00226	CcSEcCtD
Abiraterone—Menopausal symptoms—Doxorubicin—ovarian cancer	0.000456	0.00224	CcSEcCtD
Abiraterone—Anaemia—Paclitaxel—ovarian cancer	0.000453	0.00223	CcSEcCtD
Abiraterone—Cardiac disorder—Docetaxel—ovarian cancer	0.000443	0.00218	CcSEcCtD
Abiraterone—Vomiting—Topotecan—ovarian cancer	0.000442	0.00217	CcSEcCtD
Abiraterone—Cardiac failure—Doxorubicin—ovarian cancer	0.000441	0.00217	CcSEcCtD
Abiraterone—Rash—Topotecan—ovarian cancer	0.000438	0.00215	CcSEcCtD
Abiraterone—Dermatitis—Topotecan—ovarian cancer	0.000438	0.00215	CcSEcCtD
Abiraterone—Angiopathy—Docetaxel—ovarian cancer	0.000433	0.00213	CcSEcCtD
Abiraterone—Vomiting—Melphalan—ovarian cancer	0.000432	0.00213	CcSEcCtD
Abiraterone—Mediastinal disorder—Docetaxel—ovarian cancer	0.00043	0.00211	CcSEcCtD
Abiraterone—Rash—Melphalan—ovarian cancer	0.000429	0.00211	CcSEcCtD
Abiraterone—Dermatitis—Melphalan—ovarian cancer	0.000428	0.00211	CcSEcCtD
Abiraterone—Cough—Paclitaxel—ovarian cancer	0.000427	0.0021	CcSEcCtD
Abiraterone—Asthenia—Vinorelbine—ovarian cancer	0.000426	0.0021	CcSEcCtD
Abiraterone—Arrhythmia—Docetaxel—ovarian cancer	0.000426	0.0021	CcSEcCtD
Abiraterone—Hypokalaemia—Epirubicin—ovarian cancer	0.000423	0.00208	CcSEcCtD
Abiraterone—Hypertension—Paclitaxel—ovarian cancer	0.000423	0.00208	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000419	0.00206	CcSEcCtD
Abiraterone—Mental disorder—Docetaxel—ovarian cancer	0.000418	0.00205	CcSEcCtD
Abiraterone—Chest pain—Paclitaxel—ovarian cancer	0.000417	0.00205	CcSEcCtD
Abiraterone—Myalgia—Paclitaxel—ovarian cancer	0.000417	0.00205	CcSEcCtD
Abiraterone—Nasopharyngitis—Epirubicin—ovarian cancer	0.000416	0.00204	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000414	0.00204	CcSEcCtD
Abiraterone—Discomfort—Paclitaxel—ovarian cancer	0.000412	0.00203	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00041	0.00202	CcSEcCtD
Abiraterone—Diarrhoea—Vinorelbine—ovarian cancer	0.000407	0.002	CcSEcCtD
Abiraterone—Oedema—Paclitaxel—ovarian cancer	0.0004	0.00197	CcSEcCtD
Abiraterone—Infection—Paclitaxel—ovarian cancer	0.000397	0.00195	CcSEcCtD
Abiraterone—Hypokalaemia—Doxorubicin—ovarian cancer	0.000392	0.00193	CcSEcCtD
Abiraterone—Skin disorder—Paclitaxel—ovarian cancer	0.000388	0.00191	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000387	0.00191	CcSEcCtD
Abiraterone—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000385	0.00189	CcSEcCtD
Abiraterone—Anaemia—Docetaxel—ovarian cancer	0.000384	0.00189	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000379	0.00187	CcSEcCtD
Abiraterone—Vomiting—Vinorelbine—ovarian cancer	0.000378	0.00186	CcSEcCtD
Abiraterone—Rash—Vinorelbine—ovarian cancer	0.000375	0.00184	CcSEcCtD
Abiraterone—Dermatitis—Vinorelbine—ovarian cancer	0.000374	0.00184	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000373	0.00184	CcSEcCtD
Abiraterone—Pollakiuria—Epirubicin—ovarian cancer	0.000371	0.00183	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000364	0.00179	CcSEcCtD
Abiraterone—Hyperglycaemia—Epirubicin—ovarian cancer	0.000362	0.00178	CcSEcCtD
Abiraterone—Cough—Docetaxel—ovarian cancer	0.000362	0.00178	CcSEcCtD
Abiraterone—Insomnia—Paclitaxel—ovarian cancer	0.000362	0.00178	CcSEcCtD
Abiraterone—Pneumonia—Epirubicin—ovarian cancer	0.00036	0.00177	CcSEcCtD
Abiraterone—Hypertension—Docetaxel—ovarian cancer	0.000358	0.00176	CcSEcCtD
Abiraterone—Infestation NOS—Epirubicin—ovarian cancer	0.000358	0.00176	CcSEcCtD
Abiraterone—Infestation—Epirubicin—ovarian cancer	0.000358	0.00176	CcSEcCtD
Abiraterone—Dyspnoea—Paclitaxel—ovarian cancer	0.000356	0.00175	CcSEcCtD
Abiraterone—Chest pain—Docetaxel—ovarian cancer	0.000353	0.00174	CcSEcCtD
Abiraterone—Myalgia—Docetaxel—ovarian cancer	0.000353	0.00174	CcSEcCtD
Abiraterone—Dyspepsia—Paclitaxel—ovarian cancer	0.000352	0.00173	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000351	0.00173	CcSEcCtD
Abiraterone—Urinary tract infection—Epirubicin—ovarian cancer	0.000348	0.00171	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000346	0.0017	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000345	0.0017	CcSEcCtD
Abiraterone—Fatigue—Paclitaxel—ovarian cancer	0.000345	0.0017	CcSEcCtD
Abiraterone—Pollakiuria—Doxorubicin—ovarian cancer	0.000343	0.00169	CcSEcCtD
Abiraterone—Constipation—Paclitaxel—ovarian cancer	0.000342	0.00168	CcSEcCtD
Abiraterone—Haematuria—Epirubicin—ovarian cancer	0.000342	0.00168	CcSEcCtD
Abiraterone—Oedema—Docetaxel—ovarian cancer	0.000339	0.00167	CcSEcCtD
Abiraterone—Infection—Docetaxel—ovarian cancer	0.000337	0.00166	CcSEcCtD
Abiraterone—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000335	0.00165	CcSEcCtD
Abiraterone—Pneumonia—Doxorubicin—ovarian cancer	0.000333	0.00164	CcSEcCtD
Abiraterone—Testosterone—ABCB1—ovarian cancer	0.000333	0.223	CrCbGaD
Abiraterone—Infestation—Doxorubicin—ovarian cancer	0.000332	0.00163	CcSEcCtD
Abiraterone—Infestation NOS—Doxorubicin—ovarian cancer	0.000332	0.00163	CcSEcCtD
Abiraterone—Skin disorder—Docetaxel—ovarian cancer	0.000329	0.00162	CcSEcCtD
Abiraterone—Urinary tract infection—Doxorubicin—ovarian cancer	0.000322	0.00159	CcSEcCtD
Abiraterone—Urinary tract disorder—Epirubicin—ovarian cancer	0.000318	0.00156	CcSEcCtD
Abiraterone—Haematuria—Doxorubicin—ovarian cancer	0.000316	0.00155	CcSEcCtD
Abiraterone—Connective tissue disorder—Epirubicin—ovarian cancer	0.000316	0.00155	CcSEcCtD
Abiraterone—Body temperature increased—Paclitaxel—ovarian cancer	0.000316	0.00155	CcSEcCtD
Abiraterone—Urethral disorder—Epirubicin—ovarian cancer	0.000315	0.00155	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000309	0.00152	CcSEcCtD
Abiraterone—Insomnia—Docetaxel—ovarian cancer	0.000306	0.00151	CcSEcCtD
Abiraterone—Dyspnoea—Docetaxel—ovarian cancer	0.000302	0.00149	CcSEcCtD
Abiraterone—Cardiac disorder—Epirubicin—ovarian cancer	0.000299	0.00147	CcSEcCtD
Abiraterone—Dyspepsia—Docetaxel—ovarian cancer	0.000298	0.00147	CcSEcCtD
Abiraterone—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000294	0.00145	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000292	0.00144	CcSEcCtD
Abiraterone—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000292	0.00144	CcSEcCtD
Abiraterone—Fatigue—Docetaxel—ovarian cancer	0.000292	0.00144	CcSEcCtD
Abiraterone—Angiopathy—Epirubicin—ovarian cancer	0.000292	0.00144	CcSEcCtD
Abiraterone—Urethral disorder—Doxorubicin—ovarian cancer	0.000292	0.00143	CcSEcCtD
Abiraterone—Mediastinal disorder—Epirubicin—ovarian cancer	0.00029	0.00143	CcSEcCtD
Abiraterone—Constipation—Docetaxel—ovarian cancer	0.00029	0.00143	CcSEcCtD
Abiraterone—Arrhythmia—Epirubicin—ovarian cancer	0.000287	0.00141	CcSEcCtD
Abiraterone—Asthenia—Paclitaxel—ovarian cancer	0.000287	0.00141	CcSEcCtD
Abiraterone—Mental disorder—Epirubicin—ovarian cancer	0.000282	0.00139	CcSEcCtD
Abiraterone—Cardiac disorder—Doxorubicin—ovarian cancer	0.000276	0.00136	CcSEcCtD
Abiraterone—Diarrhoea—Paclitaxel—ovarian cancer	0.000273	0.00135	CcSEcCtD
Abiraterone—Angiopathy—Doxorubicin—ovarian cancer	0.00027	0.00133	CcSEcCtD
Abiraterone—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000268	0.00132	CcSEcCtD
Abiraterone—Body temperature increased—Docetaxel—ovarian cancer	0.000268	0.00132	CcSEcCtD
Abiraterone—Arrhythmia—Doxorubicin—ovarian cancer	0.000266	0.00131	CcSEcCtD
Abiraterone—Mental disorder—Doxorubicin—ovarian cancer	0.000261	0.00128	CcSEcCtD
Abiraterone—Anaemia—Epirubicin—ovarian cancer	0.000259	0.00127	CcSEcCtD
Abiraterone—Vomiting—Paclitaxel—ovarian cancer	0.000254	0.00125	CcSEcCtD
Abiraterone—Rash—Paclitaxel—ovarian cancer	0.000252	0.00124	CcSEcCtD
Abiraterone—Dermatitis—Paclitaxel—ovarian cancer	0.000252	0.00124	CcSEcCtD
Abiraterone—Cough—Epirubicin—ovarian cancer	0.000244	0.0012	CcSEcCtD
Abiraterone—Asthenia—Docetaxel—ovarian cancer	0.000243	0.0012	CcSEcCtD
Abiraterone—Hypertension—Epirubicin—ovarian cancer	0.000242	0.00119	CcSEcCtD
Abiraterone—Anaemia—Doxorubicin—ovarian cancer	0.000239	0.00118	CcSEcCtD
Abiraterone—Myalgia—Epirubicin—ovarian cancer	0.000238	0.00117	CcSEcCtD
Abiraterone—Chest pain—Epirubicin—ovarian cancer	0.000238	0.00117	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000237	0.00116	CcSEcCtD
Abiraterone—Discomfort—Epirubicin—ovarian cancer	0.000236	0.00116	CcSEcCtD
Abiraterone—Diarrhoea—Docetaxel—ovarian cancer	0.000232	0.00114	CcSEcCtD
Abiraterone—Oedema—Epirubicin—ovarian cancer	0.000229	0.00112	CcSEcCtD
Abiraterone—Infection—Epirubicin—ovarian cancer	0.000227	0.00112	CcSEcCtD
Abiraterone—Cough—Doxorubicin—ovarian cancer	0.000226	0.00111	CcSEcCtD
Abiraterone—Hypertension—Doxorubicin—ovarian cancer	0.000224	0.0011	CcSEcCtD
Abiraterone—Skin disorder—Epirubicin—ovarian cancer	0.000222	0.00109	CcSEcCtD
Abiraterone—Myalgia—Doxorubicin—ovarian cancer	0.000221	0.00108	CcSEcCtD
Abiraterone—Chest pain—Doxorubicin—ovarian cancer	0.000221	0.00108	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000219	0.00108	CcSEcCtD
Abiraterone—Discomfort—Doxorubicin—ovarian cancer	0.000218	0.00107	CcSEcCtD
Abiraterone—Vomiting—Docetaxel—ovarian cancer	0.000215	0.00106	CcSEcCtD
Abiraterone—Rash—Docetaxel—ovarian cancer	0.000214	0.00105	CcSEcCtD
Abiraterone—Dermatitis—Docetaxel—ovarian cancer	0.000213	0.00105	CcSEcCtD
Abiraterone—Oedema—Doxorubicin—ovarian cancer	0.000211	0.00104	CcSEcCtD
Abiraterone—Infection—Doxorubicin—ovarian cancer	0.00021	0.00103	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000208	0.00102	CcSEcCtD
Abiraterone—Insomnia—Epirubicin—ovarian cancer	0.000207	0.00102	CcSEcCtD
Abiraterone—Skin disorder—Doxorubicin—ovarian cancer	0.000205	0.00101	CcSEcCtD
Abiraterone—Dyspnoea—Epirubicin—ovarian cancer	0.000204	0.001	CcSEcCtD
Abiraterone—Dyspepsia—Epirubicin—ovarian cancer	0.000201	0.000989	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000197	0.00097	CcSEcCtD
Abiraterone—Fatigue—Epirubicin—ovarian cancer	0.000197	0.000969	CcSEcCtD
Abiraterone—Constipation—Epirubicin—ovarian cancer	0.000195	0.000961	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000193	0.000948	CcSEcCtD
Abiraterone—Insomnia—Doxorubicin—ovarian cancer	0.000191	0.000941	CcSEcCtD
Abiraterone—Dyspnoea—Doxorubicin—ovarian cancer	0.000189	0.000927	CcSEcCtD
Abiraterone—Dyspepsia—Doxorubicin—ovarian cancer	0.000186	0.000915	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000183	0.000898	CcSEcCtD
Abiraterone—Fatigue—Doxorubicin—ovarian cancer	0.000182	0.000897	CcSEcCtD
Abiraterone—Constipation—Doxorubicin—ovarian cancer	0.000181	0.000889	CcSEcCtD
Abiraterone—Body temperature increased—Epirubicin—ovarian cancer	0.000181	0.000889	CcSEcCtD
Abiraterone—Body temperature increased—Doxorubicin—ovarian cancer	0.000167	0.000822	CcSEcCtD
Abiraterone—Asthenia—Epirubicin—ovarian cancer	0.000164	0.000806	CcSEcCtD
Abiraterone—Diarrhoea—Epirubicin—ovarian cancer	0.000156	0.000769	CcSEcCtD
Abiraterone—Asthenia—Doxorubicin—ovarian cancer	0.000152	0.000746	CcSEcCtD
Abiraterone—Vomiting—Epirubicin—ovarian cancer	0.000145	0.000715	CcSEcCtD
Abiraterone—Diarrhoea—Doxorubicin—ovarian cancer	0.000145	0.000712	CcSEcCtD
Abiraterone—Rash—Epirubicin—ovarian cancer	0.000144	0.000709	CcSEcCtD
Abiraterone—Dermatitis—Epirubicin—ovarian cancer	0.000144	0.000708	CcSEcCtD
Abiraterone—Vomiting—Doxorubicin—ovarian cancer	0.000134	0.000661	CcSEcCtD
Abiraterone—Rash—Doxorubicin—ovarian cancer	0.000133	0.000656	CcSEcCtD
Abiraterone—Dermatitis—Doxorubicin—ovarian cancer	0.000133	0.000655	CcSEcCtD
Abiraterone—SULT2A1—Metabolism—FASN—ovarian cancer	8.14e-05	0.0019	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—SLC5A5—ovarian cancer	8e-05	0.00187	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PPP1CC—ovarian cancer	7.9e-05	0.00184	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—BRIP1—ovarian cancer	7.9e-05	0.00184	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—SLC2A1—ovarian cancer	7.73e-05	0.0018	CbGpPWpGaD
Abiraterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	7.65e-05	0.00179	CbGpPWpGaD
Abiraterone—ABCC1—Disease—BCL9—ovarian cancer	7.65e-05	0.00179	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—CYP1B1—ovarian cancer	7.58e-05	0.00177	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.57e-05	0.00177	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—SPARC—ovarian cancer	7.56e-05	0.00176	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—CYP1B1—ovarian cancer	7.47e-05	0.00174	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CYP1B1—ovarian cancer	7.41e-05	0.00173	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—RAD51C—ovarian cancer	7.3e-05	0.0017	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	7.17e-05	0.00167	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—IL2—ovarian cancer	6.77e-05	0.00158	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PPP2R1A—ovarian cancer	6.57e-05	0.00153	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.54e-05	0.00153	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—CYP1B1—ovarian cancer	6.22e-05	0.00145	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—CYP1B1—ovarian cancer	6.13e-05	0.00143	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—ABCB1—ovarian cancer	6.1e-05	0.00142	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—TYMS—ovarian cancer	5.99e-05	0.0014	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—AQP3—ovarian cancer	5.87e-05	0.00137	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.85e-05	0.00137	CbGpPWpGaD
Abiraterone—ALB—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	5.85e-05	0.00136	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	5.84e-05	0.00136	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	5.81e-05	0.00136	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.76e-05	0.00134	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PPP1CC—ovarian cancer	5.69e-05	0.00133	CbGpPWpGaD
Abiraterone—ALB—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	5.65e-05	0.00132	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—ATP7B—ovarian cancer	5.63e-05	0.00131	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	5.49e-05	0.00128	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.47e-05	0.00128	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYTB—ovarian cancer	5.45e-05	0.00127	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.33e-05	0.00124	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—YAP1—ovarian cancer	5.3e-05	0.00124	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.28e-05	0.00123	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.24e-05	0.00122	CbGpPWpGaD
Abiraterone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	5.08e-05	0.00119	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—VEGFA—ovarian cancer	4.93e-05	0.00115	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	4.89e-05	0.00114	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CAV1—ovarian cancer	4.83e-05	0.00113	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PPP1CC—ovarian cancer	4.76e-05	0.00111	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—BRIP1—ovarian cancer	4.76e-05	0.00111	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	4.7e-05	0.0011	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NME2—ovarian cancer	4.62e-05	0.00108	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.61e-05	0.00108	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.61e-05	0.00108	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NME2—ovarian cancer	4.59e-05	0.00107	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.45e-05	0.00104	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PIK3CG—ovarian cancer	4.4e-05	0.00103	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—TP53—ovarian cancer	4.35e-05	0.00101	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—FASN—ovarian cancer	4.32e-05	0.00101	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HDAC6—ovarian cancer	4.31e-05	0.00101	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—SLC5A5—ovarian cancer	4.25e-05	0.000991	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.17e-05	0.000974	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—SLC2A1—ovarian cancer	4.1e-05	0.000958	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	4.07e-05	0.000949	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.02e-05	0.000938	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	4.01e-05	0.000936	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—IL6—ovarian cancer	3.98e-05	0.000929	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP1B1—ovarian cancer	3.93e-05	0.000918	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.92e-05	0.000915	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SPARC—ovarian cancer	3.9e-05	0.00091	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.9e-05	0.000909	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PIK3CD—ovarian cancer	3.87e-05	0.000903	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NME2—ovarian cancer	3.79e-05	0.000885	CbGpPWpGaD
Abiraterone—ABCC1—Disease—XIAP—ovarian cancer	3.74e-05	0.000872	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	3.66e-05	0.000854	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SMARCA4—ovarian cancer	3.64e-05	0.00085	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EREG—ovarian cancer	3.56e-05	0.00083	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PPP2R1A—ovarian cancer	3.49e-05	0.000814	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.47e-05	0.00081	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.47e-05	0.00081	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PIK3CB—ovarian cancer	3.37e-05	0.000787	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ABCB1—ovarian cancer	3.24e-05	0.000756	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	3.22e-05	0.000751	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—YAP1—ovarian cancer	3.2e-05	0.000746	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.19e-05	0.000746	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—TYMS—ovarian cancer	3.18e-05	0.000742	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.18e-05	0.000741	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.16e-05	0.000738	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	3.16e-05	0.000738	CbGpPWpGaD
Abiraterone—ABCC1—Disease—FASN—ovarian cancer	3.11e-05	0.000726	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PARP1—ovarian cancer	3.1e-05	0.000723	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYTB—ovarian cancer	2.98e-05	0.000695	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.97e-05	0.000693	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYTB—ovarian cancer	2.96e-05	0.000691	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SLC2A1—ovarian cancer	2.95e-05	0.00069	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PTEN—ovarian cancer	2.91e-05	0.00068	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.91e-05	0.000679	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.89e-05	0.000675	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.87e-05	0.00067	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SOD1—ovarian cancer	2.83e-05	0.000661	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PPP2R1A—ovarian cancer	2.82e-05	0.000658	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	2.8e-05	0.000654	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.78e-05	0.000649	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—FASN—ovarian cancer	2.6e-05	0.000608	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPP1CC—ovarian cancer	2.6e-05	0.000607	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—BRIP1—ovarian cancer	2.6e-05	0.000607	CbGpPWpGaD
Abiraterone—ALB—Metabolism—BRIP1—ovarian cancer	2.59e-05	0.000604	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPP1CC—ovarian cancer	2.59e-05	0.000604	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	2.57e-05	0.000601	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CAV1—ovarian cancer	2.56e-05	0.000598	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—SLC5A5—ovarian cancer	2.56e-05	0.000598	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PPP2R1A—ovarian cancer	2.51e-05	0.000586	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NME2—ovarian cancer	2.48e-05	0.000579	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—SLC2A1—ovarian cancer	2.47e-05	0.000578	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.45e-05	0.000572	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYTB—ovarian cancer	2.44e-05	0.00057	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.42e-05	0.000566	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP1B1—ovarian cancer	2.37e-05	0.000554	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CG—ovarian cancer	2.33e-05	0.000545	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.26e-05	0.000529	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	2.19e-05	0.000511	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—BRIP1—ovarian cancer	2.14e-05	0.000499	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPP1CC—ovarian cancer	2.14e-05	0.000499	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PPP2R1A—ovarian cancer	2.1e-05	0.000491	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.09e-05	0.000489	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—CAV1—ovarian cancer	2.07e-05	0.000483	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	2.07e-05	0.000483	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PIK3CA—ovarian cancer	2.06e-05	0.00048	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CD—ovarian cancer	2.05e-05	0.000479	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TERT—ovarian cancer	2e-05	0.000466	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.97e-05	0.00046	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ABCB1—ovarian cancer	1.95e-05	0.000456	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—TYMS—ovarian cancer	1.92e-05	0.000448	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.9e-05	0.000443	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CG—ovarian cancer	1.89e-05	0.00044	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.89e-05	0.00044	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CAV1—ovarian cancer	1.85e-05	0.000431	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CB—ovarian cancer	1.79e-05	0.000418	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6ST—ovarian cancer	1.75e-05	0.000409	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—YAP1—ovarian cancer	1.74e-05	0.000407	CbGpPWpGaD
Abiraterone—ALB—Metabolism—YAP1—ovarian cancer	1.73e-05	0.000405	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.73e-05	0.000403	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.72e-05	0.000401	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	1.71e-05	0.000399	CbGpPWpGaD
Abiraterone—ABCC1—Disease—APC—ovarian cancer	1.68e-05	0.000393	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—AKT1—ovarian cancer	1.68e-05	0.000392	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CD—ovarian cancer	1.66e-05	0.000387	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYTB—ovarian cancer	1.6e-05	0.000373	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CAV1—ovarian cancer	1.55e-05	0.000361	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTEN—ovarian cancer	1.55e-05	0.000361	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.52e-05	0.000354	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.51e-05	0.000352	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CD—ovarian cancer	1.48e-05	0.000345	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.48e-05	0.000345	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CB—ovarian cancer	1.45e-05	0.000337	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—YAP1—ovarian cancer	1.43e-05	0.000334	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—FASN—ovarian cancer	1.42e-05	0.000332	CbGpPWpGaD
Abiraterone—ALB—Metabolism—FASN—ovarian cancer	1.41e-05	0.00033	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CG—ovarian cancer	1.41e-05	0.000329	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC5A5—ovarian cancer	1.4e-05	0.000327	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.4e-05	0.000326	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.4e-05	0.000326	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	1.4e-05	0.000326	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC5A5—ovarian cancer	1.39e-05	0.000325	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC2A1—ovarian cancer	1.35e-05	0.000315	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC2A1—ovarian cancer	1.34e-05	0.000314	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IL2—ovarian cancer	1.33e-05	0.00031	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.32e-05	0.000309	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.32e-05	0.000307	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ERBB2—ovarian cancer	1.31e-05	0.000305	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.3e-05	0.000302	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CB—ovarian cancer	1.29e-05	0.000301	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MTOR—ovarian cancer	1.29e-05	0.000301	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1B1—ovarian cancer	1.29e-05	0.000301	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CD—ovarian cancer	1.24e-05	0.000289	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN1B—ovarian cancer	1.21e-05	0.000282	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—FASN—ovarian cancer	1.17e-05	0.000273	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	1.15e-05	0.000268	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC5A5—ovarian cancer	1.15e-05	0.000268	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.14e-05	0.000267	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPP2R1A—ovarian cancer	1.14e-05	0.000267	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CTNNB1—ovarian cancer	1.14e-05	0.000267	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.14e-05	0.000265	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—ovarian cancer	1.13e-05	0.000263	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—NRAS—ovarian cancer	1.11e-05	0.00026	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTEN—ovarian cancer	1.11e-05	0.00026	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC2A1—ovarian cancer	1.11e-05	0.000259	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CA—ovarian cancer	1.09e-05	0.000255	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CB—ovarian cancer	1.08e-05	0.000252	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MAPK3—ovarian cancer	1.07e-05	0.000249	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ABCB1—ovarian cancer	1.07e-05	0.000249	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1B1—ovarian cancer	1.06e-05	0.000248	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ABCB1—ovarian cancer	1.06e-05	0.000248	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—TYMS—ovarian cancer	1.05e-05	0.000245	CbGpPWpGaD
Abiraterone—ALB—Metabolism—TYMS—ovarian cancer	1.04e-05	0.000243	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MAPK1—ovarian cancer	1.02e-05	0.000237	CbGpPWpGaD
Abiraterone—ABCC1—Disease—STAT3—ovarian cancer	9.96e-06	0.000232	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NRAS—ovarian cancer	9.93e-06	0.000232	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—KRAS—ovarian cancer	9.59e-06	0.000224	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MAPK3—ovarian cancer	9.51e-06	0.000222	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	9.43e-06	0.00022	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—YAP1—ovarian cancer	9.37e-06	0.000219	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTEN—ovarian cancer	9.32e-06	0.000218	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MYC—ovarian cancer	9.25e-06	0.000216	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MAPK1—ovarian cancer	9.05e-06	0.000211	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EGFR—ovarian cancer	9.05e-06	0.000211	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKT1—ovarian cancer	8.91e-06	0.000208	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CA—ovarian cancer	8.81e-06	0.000206	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCB1—ovarian cancer	8.76e-06	0.000204	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TYMS—ovarian cancer	8.6e-06	0.000201	CbGpPWpGaD
Abiraterone—ABCC1—Disease—KRAS—ovarian cancer	8.55e-06	0.0002	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TP53—ovarian cancer	8.52e-06	0.000199	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CAV1—ovarian cancer	8.44e-06	0.000197	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CAV1—ovarian cancer	8.39e-06	0.000196	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—HRAS—ovarian cancer	8.15e-06	0.00019	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.07e-06	0.000188	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.02e-06	0.000187	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CA—ovarian cancer	7.85e-06	0.000183	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CG—ovarian cancer	7.69e-06	0.00018	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CG—ovarian cancer	7.65e-06	0.000178	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—FASN—ovarian cancer	7.63e-06	0.000178	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	7.51e-06	0.000175	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HRAS—ovarian cancer	7.27e-06	0.00017	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	7.25e-06	0.000169	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—AKT1—ovarian cancer	7.2e-06	0.000168	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6—ovarian cancer	6.96e-06	0.000162	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	6.95e-06	0.000162	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CAV1—ovarian cancer	6.93e-06	0.000162	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CD—ovarian cancer	6.76e-06	0.000158	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CD—ovarian cancer	6.72e-06	0.000157	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CA—ovarian cancer	6.58e-06	0.000154	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKT1—ovarian cancer	6.42e-06	0.00015	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CG—ovarian cancer	6.31e-06	0.000147	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	6.17e-06	0.000144	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CB—ovarian cancer	5.89e-06	0.000138	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CB—ovarian cancer	5.86e-06	0.000137	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCB1—ovarian cancer	5.73e-06	0.000134	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TYMS—ovarian cancer	5.62e-06	0.000131	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CD—ovarian cancer	5.55e-06	0.00013	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKT1—ovarian cancer	5.37e-06	0.000125	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTEN—ovarian cancer	5.09e-06	0.000119	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTEN—ovarian cancer	5.06e-06	0.000118	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CB—ovarian cancer	4.84e-06	0.000113	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CAV1—ovarian cancer	4.53e-06	0.000106	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTEN—ovarian cancer	4.18e-06	9.76e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	4.13e-06	9.64e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.63e-06	8.47e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CA—ovarian cancer	3.59e-06	8.38e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CA—ovarian cancer	3.57e-06	8.34e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	3.16e-06	7.38e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CA—ovarian cancer	2.95e-06	6.88e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKT1—ovarian cancer	2.93e-06	6.85e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKT1—ovarian cancer	2.92e-06	6.81e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTEN—ovarian cancer	2.73e-06	6.38e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKT1—ovarian cancer	2.41e-06	5.62e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.93e-06	4.5e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKT1—ovarian cancer	1.58e-06	3.68e-05	CbGpPWpGaD
